Dendreon
Valeant to sell cancer business to Sanpower for $820m
January 10, 2017Manufacturing and Production, Sales and Marketing Dendreon, Sanpower, Valeant
Valeant Pharmaceuticals has announced it is to sell its cancer business Dendreon to Chinese firm Sanpower in a deal worth …
Another NICE no for Dendreon cancer drug
January 13, 2015Sales and Marketing Cancer, Dendreon, FDA, NHS, NICE, Provenge, sipuleucel-T
Dendreon has seen its prostate cancer treatment for people whose disease has spread and who are not yet suitable for …
Dendreon files for bankruptcy
November 12, 2014Research and Development, Sales and Marketing Dendreon, Provenge, awick, delaware, johnson, nj
Dendreon Corporation, the troubled manufacturer of high-cost cancer vaccine Provenge, has filed for bankruptcy as a prelude to restructuring its …
NICE not recommending Dendreon cancer vaccine
October 16, 2014Sales and Marketing Dendreon, NHS, NICE, Provenge, sipuleucel-T, therapeutic cancer vaccine
NICE has issued preliminary draft guidance not recommending Dendreon’s therapeutic cancer vaccine Provenge for prostate cancer in people whose disease …
Dendreon chief resigns from struggling firm
June 10, 2014Medical Communications, Sales and Marketing Cancer, Dendreon, John Johnson, Provenge, Vaccine, Watson, prostate
Chief executive of Dendreon John Johnson is to step down in the summer amid falling sales of the company’s key …
Dendreon slashes more jobs
November 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Dendreon, Provenge, cuts
Another 150 jobs are to go at Dendreon Corporation as the company seeks to cut $125 million per year in …
Dendreon slashes staff and closes facility
July 31, 2012Manufacturing and Production, Sales and Marketing Dendreon, M&P, Provenge, prostate cancer
Cancer vaccine specialist Dendreon has said it will slash 600 jobs and close one of its three manufacturing facilities in …
New chairman of the board for Dendreon
July 5, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dendreon, Provenge, johnson, prostate cancer
Dendreon has announced that its president and chief executive John Johnson has assumed the additional title of chairman of the …
Slow Provenge growth prompts Dendreon staff cull
September 13, 2011Business Services, Manufacturing and Production Dendreon, Provenge, job cuts, pharma manufacturing news
After months of building manufacturing capacity, US biotech Dendreon has decided to slash a quarter of its workforce – with …
Dendreon drops GSK as Provenge manufacturing partner
September 8, 2011Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news
Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …
Dendreon wins green light for Provenge production
March 22, 2011Manufacturing and Production Cancer, Dendreon, FDA, Provenge, pharma manufacturing, prostate cancer vaccine, sipuleucel-T
US oncology specialist Dendreon has been boosted by the approval of additional production capacity for its therapeutic prostate cancer vaccine …
Dendreon will outsource first Provenge production in EU
January 11, 2011Manufacturing and Production Dendreon, Provenge, cancer vaccine, contract manufacturing, sipuleucel-T, vaccine manufacturing, vaccines
US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …
Bavarian Nordic courting cancer vaccine backers
November 12, 2010Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan
Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …
Oxford BioMedica hopes vaccine first will raise interest
May 5, 2010Sales and Marketing Dendreon, Oxford BioMedica, Provenge, TroVax
Oxford BioMedica is hoping that the approval of the world’s first immunotherapy cancer vaccine in the US will help it …
